Data on quality of sleep, BMD and bone microarchitecture were available for 323 participants, of whom 169 were men and 154 women. Table 1 provides the demographic characteristics of the participants included in the study. The mean (SD) age of participants in the study was 75.4 (2.5) years for men and 75.7 (2.6) years for women, with the mean BMI differing little between the sexes. More significant sex differences were observed in alcohol consumption, daily dietary calcium intake and smoking habits: men consumed more alcohol per week than women (median (IQR): 6.9 units (1.8–14.0) for men, 0.5 units (0.0–4.5) for women), had a higher daily dietary calcium intake than women (median (IQR): 1233 mg (1011–1413) for men, 1087 mg (913–1254) for women), and were more prone to be or have been a smoker than women, with 41.4% of them reporting to have never smoked, whereas 63.6% of women said they had never smoked. Comorbidity affected men more than women: 24% of female participants reported having no comorbid disease, while 19.5% of men said they did not have any of the conditions listed. On the other hand, more women (10.4%) than men (7.1%) reported having 4 or more concurrent diseases. Social class distribution was similar in both sexes. The majority of women (55.1%) reported never having used HRT, with only 2.7% of them saying that they were currently using HRT.
Table 1 Baseline characteristics of study participants by biological sex The median (IQR) PSQI score was 4 (2–7) for men and 5 (3–8) for women. Thirty-seven percent of men and 43% of women had a PSQI score greater than 5, indicative of poor reported sleep quality. The mean (SD) sleep duration was 6.9 (1.1) hours per night for men and women 6.9 (1.2) hours per night for women.
PSQI overall score and individual PSQI subcomponents showed no significant association with DXA-derived areal BMD, following adjustment for confounders. Conversely, relationships were found between a PSQI score > 5 and several of the bone outcomes assessed by pQCT and HRpQCT. The associations between poor quality of sleep and bone outcomes as measured by pQCT and HRpQCT for both men and women are presented in Figs. 1 (radius) and 2 (tibia). In men, poor sleep quality was associated with lower radial mass (β − 0.32 z-score, 95% CI − 0.64, − 0.00, p < 0.05) and tBMD (β − 0.34 z-score, 95% CI − 0.65, − 0.02, p < 0.05) at 4% slice, and lower radial cBMD (β − 0.38 z-score, 95% CI − 0.70, − 0.06, p < 0.02) at 66% slice. The associations between poor sleep and these pQCT outcomes, with the exception of radial mass at 4% slice, remained significant following adjustment for confounders. We also found associations between PSQI score > 5 and HRpQCT outcomes in men: in particular, poor sleep was associated with lower radial trabecular thickness (β − 0.41 z-score, 95% CI − 0.75, − 0.06, p < 0.03), higher tibial trabecular area (β 0.37 z-score, 95% CI 0.05, 0.69, p < 0.03) and lower tibial cBMD (β − 0.35 z-score, 95% CI − 0.67, − 0.04, p = 0.03) and apparent cortical thickness (β − 0.34 z-score, 95% CI − 0.66, -0.02, p < 0.04). Following adjustment for confounders, the associations with radial trabecular thickness and tibial apparent cortical thickness were attenuated, whilst all other associations remained significant. In addition, associations between poor sleep and higher tibial Tt.Ar (β 0.38 z-score, 95% CI 0.02, 0.73, p < 0.04) and cortical porosity (β 0.37 z-score, 95% CI 0.03, 0.70 p < 0.04) became significant after adjustment for confounders.
By contrast, in women, a PSQI score > 5 was not associated with any of the pQCT outcomes assessed. Poor sleep quality was associated with a higher tibial trabecular number (β 0.35 z-score, 95% CI 0.02, 0.68, p < 0.04) in women. The association persisted following adjustment for confounders, years after menopause, and HRT use. In women, a PSQI score > 5 was associated with lower radial Ct.Ar (β − 0.41 z-score, 95% CI − 0.77, − 0.05, p < 0.03), lower cBMD (β − 0.39 z-score, 95% CI − 0.75, − 0.02, p < 0.04), apparent cortical thickness (β − 0.42 z-score, 95% CI − 0.80, − 0.05, p < 0.03) and lower tibial trabecular separation (β − 0.35 z-score, 95% CI − 0.69, − 0.02, p < 0.04), only after adjustment for confounders and sex-specific confounders.
We also analysed the relationship between individual PSQI subcomponents and bone health outcomes.
Subjective sleep quality
Poor subjective sleep quality was associated with reduced tibial polar SSI at 66% slice in men (β − 0.22 z-score, 95% CI − 0.44, − 0.00, p < 0.05), although the association no longer remained significant following adjustment for confounders. No further association was found in men. Conversely, PSQI poorer subjective sleep quality was associated with lower radial Tt.Ar (β − 0.30 z-score, 95% CI − 0.56, − 0.03, p = 0.03) and trabecular area (β − 0.30 z-score, 95% CI − 0.56, − 0.03, p = 0.03) at 4% slice in women (adjusted results).
Sleep latency
Similarly, longer sleep latency did not appear to be related to bone health outcomes in men, but was associated with higher tibial trabecular number (β 0.28 z-score, 95% CI 0.10, 0.46, p = 0.003) and lower trabecular separation (β − 0.26 z-score, 95% CI − 0.44, − 0.08, p = 0.005) in women (adjusted results).
Sleep duration
Following adjustment for confounders and sex-specific confounders, shorter sleep duration was associated with increased tibial cortical porosity in men (β 0.24 z-score, 95% CI 0.03, 0.44, p < 0.03) and lower tibial cBMD at 38% slice in women (β − 0.24 z-score, 95% CI − 0.44, − 0.04, p < 0.02).
Sleep efficiency
Poorer habitual sleep efficiency was associated with lower radial mass (β − 0.16 z-score, 95% CI − 0.31, − 0.00, p < 0.05) at 4% slice in men, following adjustment for confounders. In women, poorer habitual sleep efficiency was found to be associated with higher tibial mass at 4% slice (β 0.19 z-score, 95% CI 0.05, 0.33, p = 0.01) and trabecular number (β 0.22 z-score, 95% CI 0.07, 0.37, p = 0.005), and decreased trabecular separation (β -0.22 z-score, 95% CI − 0.36, − 0.07, p = 0.005), following adjustment for confounders, years after menopause and HRT use.
Sleep disturbance
In men, sleep disturbance was associated with increased radial total density (β 0.31 z-score, 95% CI 0.01, 0.61, p < 0.05) at 4% slice, and tibial cBMD at 38% slice (β 0.36 z-score, 95% CI 0.06, 0.65, p = 002) and 66% slice (β 0.33 z-score, 95% CI 0.02, 0.65, p < 0.04), after adjustment. In women, this PSQI domain was associated with decreased radial cortical porosity (β − 0.39 z-score, 95% CI − 0.76, − 0.03, p < 0.04) following adjustment for confounders and sex-specific confounders.
Sleep medication
A higher frequency of use of sleep medications was associated with lower tibial SSI (β − 0.20 z-score, 95% CI − 0.41, − 0.00, p < 0.05), and Tt.Ar at 38% slice (β − 0.22 z-score, 95% CI − 0.42, − 0.01, p < 0.04) and 66% slice (β − 0.21 z-score, 95% CI − 0.42, − 0.00, p < 0.05) in women after adjustment, but no association was found in men. It must be noted that women reported a higher use of sleep medications within a month (13.8%) than men (8.9%), although the difference between sexes was not statistically significant (p = 0.167).
Daytime dysfunction
No relationship was found between increased daytime dysfunction and bone health outcomes in neither men nor women, once results had been adjusted for confounders and sex-specific confounders.